Tarja Stenvall
President & CEOMs. Tarja Stenvall is the President & CEO of Bavarian Nordic A/S since October 15, 2026. Ms. Stenvall previously served at Sanofi as the Senior Vice President and Head of Global Franchise for diabetes and cardiovascular diseases, Senior Vice President for Key Markets in General Medicines, Senior Vice President for Europe and Vice President for Vaccines in Latin America. Ms. Stenvall joined Sanofi in 2014 and served as a member of the Global Business Unit Leadership Team and the Global Sanofi Sustainability Impact Committee. Ms. Stenvall held commercial leadership roles at AstraZeneca and commercial leadership positions in Pfizer. Ms. Stenvall holds a degree in Economics from Aalto University (formerly the Helsinki School of Economics and Business Administration) in Finland and an MBA in International Business from the University of South Carolina in the US.
Positions
- Company NameBavarian Nordic A/SStock CodeBVNRYPositionPresident & CEOColleagues
- HJHenrik JuuelCFO & Executive VP
- ALAnne Louise EberhardIndependent Chair
- RTRussell ThirskExecutive VP & COO
- NSNicole SeroffVice President Corporate Communications
- JMJean-Christophe MayExecutive VP & Chief Commercial Officer
- HHHeidi HunterIndependent Vice Chairman of the Board
- HMHans Martin SmithIndependent Director
- FAFranciscus A. G. M. VerwielIndependent Director
- AGAnja GjolEmployee-Elected Member of the Board
